Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

Older Americans previously could only access GLP-1 coverage for diabetes or cardiovascular disease through Medicare. See if you qualify now. Some Medicare patients will soon have access to GLP-1 drugs ...

Medicare Part D is introducing important prescription drug cost updates in 2026, including higher deductibles, a new ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the ...

Medicare drug plan changes in 2026 may raise your prescription costs. Here is what beneficiaries need to know about ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

As anti-obesity drugs Wegovy (semaglutide) and Mounjaro (tirzepatide) will be reimbursed as of Monday, June 15, the secretaries of the specialized obesity center (CSO) at the Pitié-Salpêtrière ...

For stories on healthy living, subscribe to NPR's Health newsletter. Every time David Davis talks to a nurse at Vida Health, he thinks he'll finally get the OK for Zepbound. And every time so far he ...